Closing date soon. Become a member of an exciting international collaboration researching ways to benefit prostate cancer patients through the analysis of next generation sequencing data combined with high quality clinical and histopathology information. https://t.co/0hoHvsoxU3 https://t.co/0EPBpzefyY
Closing date soon. Become a member of an exciting international collaboration researching ways to benefit prostate cancer patients through the analysis of next generation sequencing data combined with high quality clinical and histopathology information. https://t.co/0hoHvsoxU3 pic.twitter.com/0EPBpzefyY
— Daniel Brewer (@danbrewer) March 2, 2020
from Twitter https://twitter.com/danbrewer
Comments